| CEO Name | Dimitri de Vreeze |
| Nationality | Netherlands |
| Net Worth Estimation | $25 million |
Dimitri de Vreeze's estimated net worth of around $25 million is primarily derived from his executive compensation, long-term incentives, and stock holdings as CEO of Royal DSM N.V. His financial standing reflects DSM's robust market capitalization, performance-based rewards, and his long tenure with the company.
Dimitri de Vreeze, CEO of Royal DSM N.V., has an estimated net worth of 25,000,000 USD, which is approximately 27.8% of the maximum CEO net worth in the manufacturing sector (90,000,000 USD). His net worth is significantly above the minimum for this category, which is 0 USD.
Business Category: Manufacturing
Minimum Net Worth (estimation): 0 USD
Maximum Net Worth (estimation): 90000000 USD
Dimitri de Vreeze Performance in Royal DSM N.V.
Dimitri de Vreeze, CEO of Royal DSM N.V., demonstrates strategic leadership by driving innovation and sustainability-focused decision-making that aligns with DSM's purpose-led growth. His performance emphasizes operational efficiency and market expansion, advancing DSM's position in health, nutrition, and bioscience sectors. Under his leadership, DSM has enhanced shareholder value and strengthened its global impact on sustainable business practices.
Latest News
Royal DSM N.V. and CEO Update 2025
Royal DSM N.V., now operating as DSM-Firmenich post-merger, reports strong organic sales growth and strategic realignment in H1 2025 under CEO Dimitri de Vreeze, focusing on innovation, portfolio sharpening, and financial discipline. Alexander Wessels leads DSM Pharmaceutical Products, supporting DSM's growth in high-margin markets with a background in life sciences and nutrition industries. The company aims for EUR2.4 billion adjusted EBITDA and emphasizes sustainable nutrition, health, and beauty solutions.
Source: http://nutritioninsight.com/news/dsm-firmenich-h1-2025-financial-results-strategy.html